Literature DB >> 29713012

Prions, prionoids and protein misfolding disorders.

Claudia Scheckel1, Adriano Aguzzi2.   

Abstract

Prion diseases are progressive, incurable and fatal neurodegenerative conditions. The term 'prion' was first nominated to express the revolutionary concept that a protein could be infectious. We now know that prions consist of PrPSc, the pathological aggregated form of the cellular prion protein PrPC. Over the years, the term has been semantically broadened to describe aggregates irrespective of their infectivity, and the prion concept is now being applied, perhaps overenthusiastically, to all neurodegenerative diseases that involve protein aggregation. Indeed, recent studies suggest that prion diseases (PrDs) and protein misfolding disorders (PMDs) share some common disease mechanisms, which could have implications for potential treatments. Nevertheless, the transmissibility of bona fide prions is unique, and PrDs should be considered as distinct from other PMDs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29713012     DOI: 10.1038/s41576-018-0011-4

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  70 in total

1.  Alterations in neuronal metabolism contribute to the pathogenesis of prion disease.

Authors:  Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert
Journal:  Cell Death Differ       Date:  2018-06-18       Impact factor: 15.828

2.  Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.

Authors:  Jianling Xie; Petra Van Damme; Danielle Fang; Christopher G Proud
Journal:  J Biol Chem       Date:  2019-03-19       Impact factor: 5.157

Review 3.  Genetically engineered cellular models of prion propagation.

Authors:  Hamza Arshad; Joel C Watts
Journal:  Cell Tissue Res       Date:  2022-05-18       Impact factor: 5.249

Review 4.  Prions and prion diseases: Insights from the eye.

Authors:  Neena Singh; Suman Chaudhary; Ajay Ashok; Ewald Lindner
Journal:  Exp Eye Res       Date:  2020-08-25       Impact factor: 3.467

5.  Yeast-based screening of natural product extracts results in the identification of prion inhibitors from a marine sponge.

Authors:  Laurence K Jennings; Ishtiaq Ahmed; Alan L Munn; Anthony R Carroll
Journal:  Prion       Date:  2018-09-13       Impact factor: 3.931

Review 6.  Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.

Authors:  Maria Elena Cicardi; Lara Marrone; Mimoun Azzouz; Davide Trotti
Journal:  EMBO J       Date:  2021-03-31       Impact factor: 11.598

7.  Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.

Authors:  Aline Bamia; Maha Sinane; Rima Naït-Saïdi; Jamila Dhiab; Frédéric Bihel; Cécile Voisset; Marc Keruzoré; Phu Hai Nguyen; Agathe Bertho; Flavie Soubigou; Sophie Halliez; Marc Blondel; Capucine Trollet; Martine Simonelig; Gaëlle Friocourt; Vincent Béringue
Journal:  Neurotherapeutics       Date:  2021-02-02       Impact factor: 7.620

Review 8.  Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders.

Authors:  Chinmaya Panda; Rajani Kanta Mahapatra
Journal:  Cell Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.046

9.  Intercellular transport of Tau protein and β-amyloid mediated by tunneling nanotubes.

Authors:  Kejia Zhang; Zehui Sun; Xinyu Chen; Yifan Zhang; Angyang Guo; Yan Zhang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 10.  Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.

Authors:  Priscila Baltazar Gonçalves; Ana Carolina Rennó Sodero; Yraima Cordeiro
Journal:  Biomolecules       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.